Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation

  • Hannah Petraitis Kuschman
  • , Marianne B. Palczewski
  • , Brian Hoffman
  • , Mary Menhart
  • , Xiaowei Wang
  • , Sharon Glynn
  • , Abul B.M.M.K. Islam
  • , Elizaveta V. Benevolenskaya
  • , Douglas D. Thomas

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

9 Citations (Scopus)

Abstract

N6-methyladenosine (m6A) is the most abundant internal modification on eukaryotic mRNAs. Demethylation of m6A on mRNA is catalyzed by the enzyme fat mass and obesity-associated protein (FTO), a member of the nonheme Fe(II) and 2-oxoglutarate (2-OG)-dependent family of dioxygenases. FTO activity and m6A-mRNA are dysregulated in multiple diseases including cancers, yet endogenous signaling molecules that modulate FTO activity have not been identified. Here we show that nitric oxide (NO) is a potent inhibitor of FTO demethylase activity by directly binding to the catalytic iron center, which causes global m6A hypermethylation of mRNA in cells and results in gene-specific enrichment of m6A on mRNA of NO-regulated transcripts. Both cell culture and tumor xenograft models demonstrated that endogenous NO synthesis can regulate m6A-mRNA levels and transcriptional changes of m6A-associated genes. These results build a direct link between NO and m6A-mRNA regulation and reveal a novel signaling mechanism of NO as an endogenous regulator of the epitranscriptome.

Original languageEnglish
Article number102928
JournalRedox Biology
Volume67
DOIs
Publication statusPublished - Nov 2023

Fingerprint

Dive into the research topics of 'Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation'. Together they form a unique fingerprint.

Cite this